Company intelligence / Profile preview
Changzhou Fangyuan Pharmaceutical
Changzhou, Jiangsu, Chinafangyuan-pharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company is advancing a portfolio of novel aminoglycoside antibiotics and other small molecule therapeutics. The lead program, arbekacin, is targeting superbug (MRSA and Gram-negative) infections and has completed pre-clinical work in China, with trials planned. Additional candidates (FY-01, FY-02, FY-901) are in pre-clinical stages and target MRSA, tuberculosis, leukemia, and colon cancer. No pivotal clinical trial results are published yet[3][4][6][7][8].
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small moleculeBiologicAminoglycoside antibiotic
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Academic: Chinese Academy of Engineering/ Wang Guangji Academic Workstation[4]Multiple collaborations with universities and research institutes[2][3]
Beyond the preview
Go deeper on Changzhou Fangyuan Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Changzhou Fangyuan Pharmaceutical.